Yüklüyor......
Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
The heterogeneity of tumor is considered as a major difficulty to victorious personalized cancer medicine. There is an extremeneed of consistent response evaluation for in vivo tumor heterogeneity anditscoupledconflict mechanisms. In this occasion researchers will be able to keep pace withpredictive...
Kaydedildi:
| Yayımlandı: | J Diabetes Metab Disord |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6154523/ https://ncbi.nlm.nih.gov/pubmed/30288382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40200-018-0334-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|